AACR logo

More articles from Research Articles

Identification of Internalizing Human Single-Chain Antibodies Targeting Brain Tumor Sphere Cells
Xiaodong Zhu, Scott Bidlingmaier, Rintaro Hashizume, C. David James, Mitchel S. Berger, Bin Liu

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2131-2141; DOI: 10.1158/1535-7163.MCT-09-1059
A Genetically Encoded Multifunctional TRAIL Trimer Facilitates Cell-Specific Targeting and Tumor Cell Killing
Dirk Spitzer, Jonathan E. McDunn, Stacey Plambeck-Suess, Peter S. Goedegebuure, Richard S. Hotchkiss, William G. Hawkins

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2142-2151; DOI: 10.1158/1535-7163.MCT-10-0225
Effective Therapeutic Targeting of the Overexpressed HER-2 Receptor in a Highly Metastatic Orthotopic Model of Esophageal Carcinoma
Stephanie J. Gros, Nina Kurschat, Thorsten Dohrmann, Uta Reichelt, Ana-Maria Dancau, Kersten Peldschus, Gerhard Adam, Robert M. Hoffman, Jakob R. Izbicki, Jussuf T. Kaifi

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2037-2045; DOI: 10.1158/1535-7163.MCT-10-0209
Mcl-1 Stability Determines Mitotic Cell Fate of Human Multiple Myeloma Tumor Cells Treated with the Kinesin Spindle Protein Inhibitor ARRY-520
Brian J. Tunquist, Richard D. Woessner, Duncan H. Walker

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2046-2056; DOI: 10.1158/1535-7163.MCT-10-0033
Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer
David L. Schwartz, James A. Bankson, Robert Lemos, Stephen Y. Lai, Arun K. Thittai, Yi He, Galen Hostetter, Michael J. Demeure, Daniel D. Von Hoff, Garth Powis

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2057-2067; DOI: 10.1158/1535-7163.MCT-09-0768
Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
Hop S. Tran Cao, Michael Bouvet, Sharmeela Kaushal, Alex Keleman, Eric Romney, Ginna Kim, John Fruehauf, David K. Imagawa, Robert M. Hoffman, Matthew H.G. Katz

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2068-2078; DOI: 10.1158/1535-7163.MCT-10-0201
Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Yan Degenhardt, Joel Greshock, Sylvie Laquerre, Aidan G. Gilmartin, Junping Jing, Mark Richter, Xiping Zhang, Maureen Bleam, Wendy Halsey, Ashley Hughes, Christopher Moy, Nancy Liu-Sullivan, Scott Powers, Kurtis Bachman, Jeffrey Jackson, Barbara Weber, Richard Wooster

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2079-2089; DOI: 10.1158/1535-7163.MCT-10-0095
Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy
Christina K. Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M. Angelica Selim, James Burchette, Georgia M. Beasley, Nicole McMahon, James Padussis, Scott K. Pruitt, Francis Ali-Osman, Douglas S. Tyler

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2090-2101; DOI: 10.1158/1535-7163.MCT-10-0073
p53-Independent Induction of G₁ Arrest and p21^WAF1/CIP1 Expression by Ascofuranone, an Isoprenoid Antibiotic, through Downregulation of c-Myc
Ji-Hak Jeong, Shin-Sung Kang, Kwan-Kyu Park, Hyeun-Wook Chang, Junji Magae, Young-Chae Chang

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2102-2113; DOI: 10.1158/1535-7163.MCT-09-1159
Silencing of Integrated Human Papillomavirus-16 Oncogenes by Small Interfering RNA–Mediated Heterochromatization
Jayanth Kumar Palanichamy, Mohit Mehndiratta, Mohita Bhagat, Pradeep Ramalingam, Brati Das, Prerna Das, Subrata Sinha, Parthaprasad Chattopadhyay

Molecular Cancer Therapeutics Jul 2010, 9 (7) 2114-2122; DOI: 10.1158/1535-7163.MCT-09-0977

Main menu

User menu

Search

More articles from Research Articles

Pages

Articles

Info for

About MCT